IRTC logo

IRHYTHM HOLDINGS INC

IRTCNASDAQ
πŸ† #1411 by market capEarnings Nov 5US Equity
$127.99β–² $3.94 (+3.18%)
Latest quote
πŸ””
Track IRTC
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 3.2%
7dβ–² 6.9%
14dβ–² 17.1%
30dβ–² 11.9%
ytdβ–Ό 27.7%
1yβ–Ό 30.9%
🏦Market Cap
$4.22B
Small Cap
πŸ“ˆRevenue Growth (YoY)
25.6%
High Growth
πŸ“ŠGross Margin
71.5%
High
πŸ’΅FCF Margin
8.7%
Moderate
βš–οΈP/S Ratio
4.9x
Fair
Otter Score
72
Strong

Trading Snapshot

Day Range
$125.55 – $128.14
52-Week Range
$100.70 – $212.00
Volume (shares)
33,779
Avg Volume (shares)
β€”
Shares Outstanding
33.0M
Next Earnings
2026-11-05

Fundamentals Snapshot

Annual Revenue
$747M
Last Q Revenue
$224M
P/E Ratio
β€”
P/S Ratio
4.9x
EPS (TTM)
$-0.43
Dividend Yield
β€”
Dilution (1yr)
+6.3%
IRTC logo

IRHYTHM HOLDINGS INC

IRTC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$747Mβ–² +26.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
70.6%β–² +2.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$37Mβ–Ό βˆ’68.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$35Mβ–Ό βˆ’175.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
33.3Mβ–² +6.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$495Mβ–Ό βˆ’$178M YoY
StockOtter Β· stockotter.space

About IRHYTHM HOLDINGS INC

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensorβ€”specifically embodied in products like the Zio XT and AT monitorsβ€”with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
72/100

Analyst Ratings

β“˜
Consensus
Buy
21 analysts
Strong Buy10
Buy10
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.